Hacker News new | ask | show | jobs
by xeckr 960 days ago
The FDA's press release didn't say anything about the success rate, only that the test group had significantly lower levels of depression than the control group. It's true that a lot of antidepressants fail to improve symptoms in a lot of people. The effectiveness of this particular drug better be outstanding, otherwise Biogen-Sage won't be able to justify the high price compared to other antidepressants.